Peter Anderson: Clinical Trials

1 trial sponsored by Peter Anderson, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Peter Anderson: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Study of ONC201 in Neuroendocrine Tumors
ONC201 - Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor
Phase 2CompletedPeter Anderson302017-08-022024-11-26

Conditions studied

Neuroendocrine Tumors (1)

Interventions

TIC10 compound (1)

Countries

United States (1)

Top investigators

Peter M Anderson, MD, PhD (1)

Results publications

PMID 35022321